This article makes the case for a simplified, pragmatic approach to heart failure (HF) screening in primary care. By focusing on common comorbidities like obesity and kidney disease, clinicians can better identify patients who may be misdiagnosed as asymptomatic. Early initiation of SGLT2 inhibitors is proposed as a cost-effective strategy to improve outcomes before the onset of irreversible damage.